Clinical Trials Directory

Trials / Completed

CompletedNCT00550368

Clinical Experiment of Helicobacter Pylori Transmission

Effect of Gastric Acid and H. Pylori Infection on Infection With Enteropathogenic E. Coli

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
35 Years – 59 Years
Healthy volunteers
Accepted

Summary

The study proposes to test whether chronic infection with Helicobacter pylori protects individuals from symptomatic infection with enteropathogenic E. coli. The study will also evaluate the effect of gastric acidity in this relationship.

Detailed description

Because H. pylori is an enteric infection, its prevalence may be linked to exposure to other enteric pathogens. Results of observational studies on the association between H. pylori and gastroenteritis, however, have been conflicting. Some have shown increased incidence of diarrhea in children with H. pylori infection, with one study attributing 11% of diarrhea cases to H. pylori. Other studies found no association, and still others found a protective effect of H. pylori against gastroenteritis. Dissecting out confounding from true physiological associations can be difficult in observational studies. To better elucidate the association between H. pylori and gastroenteritis, we performed a direct challenge experiment with a well-characterized gastrointestinal pathogen, enteropathogenic Escherichia coli (EPEC). EPEC is a leading cause of infantile gastroenteritis in the world and has a long history of safe use in human experiments. It is also acid sensitive: in our laboratory less than 0.001% of inoculated EPEC organisms survived at pH 2.5. Our goal was to test the hypothesis that chronic infection with H. pylori increases the risk of diarrheal illness after direct challenge with EPEC.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBiological intervention: Enteropathogenic E. coli5x10\^8 or 1x10\^9 organisms of EPEC were administered to all participants.

Timeline

Start date
2005-08-01
Primary completion
2009-04-01
Completion
2009-04-01
First posted
2007-10-29
Last updated
2016-12-06
Results posted
2016-12-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00550368. Inclusion in this directory is not an endorsement.